Evidence, not fear, should guide the FDA’s vaping policies

Evidence, not fear, should guide the FDA’s vaping policies

In a recent appearance on Politico’s The Conversation podcast, Food and Drug Administration (FDA) Commissioner Marty Makary stressed the importance of building stakeholder consensus and incorporating broad input on policy issues, while grounding decisions in evidence. Yet, in the same discussion, he described a “child vaping epidemic” and signaled plans for increased supply controls.  The latest National Youth Tobacco Survey found that 5.9 perce…